Literature DB >> 21498553

Survival of cancer in patients with rheumatoid arthritis: a follow-up study in Sweden of patients hospitalized with rheumatoid arthritis 1 year before diagnosis of cancer.

Jianguang Ji1, Xiangdong Liu, Kristina Sundquist, Jan Sundquist.   

Abstract

OBJECTIVES: Patients diagnosed with RA have an increased risk of some cancers. However, limited data are available on the important issue of prognosis of RA patients with cancer.
METHODS: RA patients were identified from the Swedish Hospital Discharge Register by linkage to the Cancer Registry. Follow-up of patients was started from the date of diagnosis of cancer through year 2006. Hazard ratios (HRs) were calculated in cancer patients with RA compared with subjects without RA.
RESULTS: A total of 1,411,163 cancer patients were identified in the database, of whom 6309 had a previous hospitalization for RA. Compared with all cancer patients without RA, patients with RA had a worse prognosis, with an HR of 1.29 and 1.31 for cause-specific and overall survival, respectively. For specific cancer sites, skin and breast cancers and non-Hodgkin's lymphoma showed worst survival. Age stratification did not change the results.
CONCLUSION: Cancer patients with a previous hospitalization for RA had a worse prognosis for all and many site-specific cancers compared with patients without RA, independent of age at diagnosis and tumour staging. Improvement of survival for cancer patients with RA may require a multidisciplinary approach to accommodate the comorbidity.

Entities:  

Mesh:

Year:  2011        PMID: 21498553     DOI: 10.1093/rheumatology/ker143

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  17 in total

1.  Non-steroidal anti-inflammatory drug use, hormone receptor status, and breast cancer-specific mortality in the Carolina Breast Cancer Study.

Authors:  E H Allott; C-K Tse; A F Olshan; L A Carey; P G Moorman; M A Troester
Journal:  Breast Cancer Res Treat       Date:  2014-08-24       Impact factor: 4.872

2.  Multimorbidity: an issue of growing importance for oncologists.

Authors:  Christine S Ritchie; Elizabeth Kvale; Michael J Fisch
Journal:  J Oncol Pract       Date:  2011-11       Impact factor: 3.840

3.  Chronic disease burden among cancer survivors in the California Behavioral Risk Factor Surveillance System, 2009-2010.

Authors:  Heather P Tarleton; Suzanne Ryan-Ibarra; Marta Induni
Journal:  J Cancer Surviv       Date:  2014-04-09       Impact factor: 4.442

4.  Does celiac disease influence survival in lymphoproliferative malignancy?

Authors:  Jonas F Ludvigsson; Benjamin Lebwohl; Alberto Rubio-Tapia; Joseph A Murray; Peter H R Green; Anders Ekbom; Fredrik Granath
Journal:  Eur J Epidemiol       Date:  2013-03-05       Impact factor: 8.082

Review 5.  [Gynecological cancers in patients with inflammatory rheumatic diseases].

Authors:  M Schmalzing; M Krockenberger; A Honig; H-P Tony
Journal:  Z Rheumatol       Date:  2016-02       Impact factor: 1.372

Review 6.  Lung cancer in rheumatoid arthritis. Is there a need for better risk assessment and screening?

Authors:  George E Fragoulis; Katerina Chatzidionysiou
Journal:  Clin Rheumatol       Date:  2019-12-13       Impact factor: 2.980

7.  The Prevalence of Systemic Rheumatic Diseases Among Breast Cancer Patients and Its Relationship With Survival.

Authors:  Veli Sunar; Öztürk Ateş; Alma Korcali Aslan; Yusuf Karakaş; Mustafa Kadri Altundağ
Journal:  Arch Rheumatol       Date:  2018-08-16       Impact factor: 1.472

8.  Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma.

Authors:  Kari Hemminki; Xiangdong Liu; Asta Försti; Jianguang Ji; Jan Sundquist; Kristina Sundquist
Journal:  J Hematol Oncol       Date:  2012-10-02       Impact factor: 17.388

9.  Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-Kit signaling.

Authors:  Lopamudra Das Roy; Jennifer M Curry; Mahnaz Sahraei; Dahlia M Besmer; Amritha Kidiyoor; Helen E Gruber; Pinku Mukherjee
Journal:  Breast Cancer Res       Date:  2013-04-11       Impact factor: 6.466

10.  Autoimmune diseases and hypersensitivities improve the prognosis in ER-negative breast cancer.

Authors:  Rickard Einefors; Ulrika Kogler; Carolina Ellberg; Håkan Olsson
Journal:  Springerplus       Date:  2013-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.